Carsten Niemann
Clinical Associate Professor
Department of Clinical Medicine
Blegdamsvej 9, 2100 København Ø
Member of:
Internal Medicine: Haematology
- Published
Ibrutinib and venetoclax for first-line treatment of CLL
Kater, A. P., Levin, M. D. & Niemann, Carsten, 2019, In: New England Journal of Medicine. 381, 8, p. 788-789 2 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation
Kielbassa, K., Haselager, M. V., Bax, D. J. C., van Driel, B. F., Dubois, J., Levin, M. D., Kersting, S., Svanberg, R., Niemann, Carsten, Kater, A. P. & Eldering, E., 2023, In: Leukemia. 37, 6, p. 1268-1276 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV
Klausen, U., Grauslund, J. H., Jørgensen, N. G. D., Ahmad, S. M., Jonassen, M., Weis-Banke, S. E., Martinenaite, E., Pedersen, L. B., Lisle, T. L., Gang, Anne Ortved, Enggaard, L., Hansen, M., Holmström, M. O., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2022, In: Frontiers in Oncology. 12, 1023015.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma
Klausen, U., Grønne Dahlager Jørgensen, N., Grauslund, J. H., Munir Ahmad, S., Gang, Anne Ortved, Martinenaite, E., Weis-Banke, S. E., Breinholt, M. F., Novotny, G. W., Kjeldsen, J. W., Orebo Holmström, M., Pedersen, L. B., Poulsen, C. B., Hansen, P. B., Met, Özcan, Svane, Inge Marie, Niemann, Carsten, Pedersen, Lars Møller & Andersen, Mads Hald, 2021, In: OncoImmunology. 10, 1, 1975889.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years
Kolstad, A., Pedersen, L. B., Eskelund, C. W., Husby, S., Grønbæk, K., Jerkeman, M., Laurell, A., Räty, R., Elonen, E., Andersen, N. S., Brown, P. D. N., Kimby, E., Bentzen, H., Sundström, C., Ehinger, M., Karjalainen-Lindsberg, M. L., Delabie, J., Ralfkiær, E., Fagerli, U. M., Nilsson-Ehle, H. & 5 others, , Mar 2017, In: Biology of Blood and Marrow Transplantation. 23, 3, p. 428-435 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy
Kyvsgaard, Emil Ramsø, Riley, C., Clausen, M. R., Harsløf, Mads, Heftdal, Line Dam, Niemann, Carsten, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 2024, In: British Journal of Haematology. 204, 1, p. 356-360 5 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
Lokhande, L., Kuci Emruli, V., Eskelund, C. W., Kolstad, A., Hutchings, M., Räty, R., Niemann, Carsten, Grønbæk, Kirsten, Jerkeman, M. & Ek, S., 2022, In: Cancer Reports. 5, 8 p., e1524.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
Lorenzovici, L., Szilberhorn, L., Farkas-Ráduly, S., Gasparik, A. I., Precup, A. M., Nagy, A. G., Niemann, Carsten, Aittokallio, T., Kaló, Z. & Csanádi, M., 2023, In: BioDrugs. 37, 2, p. 219-233 15 p.Research output: Contribution to journal › Review › Research › peer-review
- Published
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia - Update on methodological approaches and results interpretation
Malcikova, J., Tausch, E., Rossi, D., Sutton, L. A., Soussi, T., Zenz, T., Kater, A. P., Niemann, Carsten, Gonzalez, D., Davi, F., Gonzalez Diaz, M., Moreno, C., Gaidano, G., Stamatopoulos, K., Rosenquist, R., Stilgenbauer, S., Ghia, P. & Pospisilova, S., 1 May 2018, In: Leukemia. 32, 5, p. 1070-1080Research output: Contribution to journal › Review › Research › peer-review
- Published
Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
Mansouri, L., Thorvaldsdottir, B., Sutton, L. A., Karakatsoulis, G., Meggendorfer, M., Parker, H., Nadeu, F., Brieghel, C., Laidou, S., Moia, R., Rossi, D., Catherwood, M., Kotaskova, J., Delgado, J., Rodríguez-Vicente, A. E., Benito, R., Rigolin, G. M., Bonfiglio, S., Scarfo, L., Mattsson, M. & 41 others, , 2023, In: Leukemia. 37, 2, p. 339-347 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients Admitted to Hospital With Coronavirus Disease 2019 (COVID-19)
Moestrup, K. S., Reekie, J., Zucco, Adrian G., Jensen, T. Ø., Jensen , Jens-Ulrik Stæhr , Wiese, L., Ostrowski, Sisse Rye, Niemann, Carsten, MacPherson, C. R., Lundgren, Jens & Helleberg, Marie, 8 Feb 2023, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76, 3, p. e82-e89 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
CLL-106 First Prospective Data on Minimal Residual Disease Outcomes After Fixed-Duration Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for First-Line Treatment of CLL in Older Adult or Unfit Patients: The GLOW Study
Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M. D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, Q., Steele, A., Schuier, N., Baeten, K., Caces, D. B. & 2 others, , 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S264-S265Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
- Published
Impact of Minimal Residual Disease on Progression-Free Survival Outcomes after Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study
Munir, T., Moreno, C., Owen, C., Follows, G., Benjamini, O., Janssens, A., Levin, M. D., Osterborg, A., Robak, T., Simkovic, M., Stevens, D., Voloshin, S., Vorobyev, V., Yagci, M., Ysebaert, L., Qi, K., Qi, Q., Parisi, L., Srinivasan, S., Schuier, N. & 5 others, , 2023, In: Journal of Clinical Oncology. 41, 21, p. 3689-3699 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
Niemann, Carsten, Levin, M., Dubois, J., Kersting, S., Enggaard, L., Veldhuis, G. J., Mous, R., Mellink, C. H. M., Dobber, J. A., Poulsen, C. B., Frederiksen, H., Janssens, A., Schjødt, I., Dompeling, E. C., Ranti, J., Mattsson, M., Bellido, M., Tran, H. T. T., Nasserinejad, K. & Kater, A. P., 2021, In: Blood. 137, 8, p. 1117-1120Research output: Contribution to journal › Letter › Research › peer-review
- Published
COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study
Niemann, Carsten, Awan, F. T., Fogliatto, L., Nikitin, E., Samoilova, O., Habib, A., Foroutanpour, K., Kuptsova-Clarkson, N. & Opat, S., 2022, In: HemaSphere. 6, 10, p. E780Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Patients with CLL have a lower risk of death from COVID-19 in the Omicron era
Niemann, Carsten, da Cunha-Bang, C., Helleberg, M., Ostrowski, Sisse Rye & Brieghel, C., 2022, In: Blood. 140, 5, p. 445-450 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Cost-effectiveness targeting CLL
Niemann, Carsten, 2020, In: Blood. 136, 17, p. 1896-1898Research output: Contribution to journal › Editorial › Research › peer-review
- Published
BTK inhibitors: safety + efficacy = outcome
Niemann, Carsten, 2023, In: Blood. 142, 8, p. 679-680 2 p.Research output: Contribution to journal › Comment/debate › Research › peer-review
- Published
Immediate COVID-19 treatment in CLL
Niemann, Carsten, 2023, In: Blood. 141, 18, p. 2167-2168 2 p.Research output: Contribution to journal › Editorial › Research › peer-review
- Published
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data
Parviz, M., Brieghel, C., Agius, R. & Niemann, Carsten, 2022, In: Blood advances. 6, 12, p. 3716-3728 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Identifying CLL patients at high risk of atrial fibrillation on treatment using machine learning
Parviz, M., Agius, R., Rotbain, E. C., Vainer, N., Aarup, K. & Niemann, Carsten, 2024, In: Leukemia and Lymphoma. 65, 4, p. 449-459 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial
Pettengell, R., Uddin, R., Boumendil, A., Johnson, R., Metzner, B., Martín, A., Romejko-Jarosinska, J., Bence-Bruckler, I., Giri, P., Niemann, Carsten, Robinson, S. P., Kimby, E., Schmitz, N., Dreger, P., Goldstone, A. H. & Montoto, S., 2021, In: Bone Marrow Transplantation. 56, 6, p. 1413-1421 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
Rawstron, A. C., Kreuzer, K., Soosapilla, A., Spacek, M., Stehlikova, O., Gambell, P., Mciver-brown, N., Villamor, N., Psarra, K., Arroz, M., Milani, R., De La Serna, J., Cedena, M. T., Jaksic, O., Nomdedeu, J., Moreno, C., Rigolin, G. M., Cuneo, A., Johansen, P., Johnsen, H. E. & 13 others, , 2018, In: Cytometry. Part B: Clinical Cytometry. 94, 1, p. 121-128 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Increased incidence rates of positive blood cultures shortly after chemotherapy compared to radiotherapy among individuals treated for solid malignant tumours
Roen, A., Terrones, C., Bannister, W., Helleberg, M., Andersen, M. A., Niemann, Carsten, Daugaard, G., Specht, Lena, Mocroft, A., Reekie, J. & Lundgren, Jens, 2023, In: Infection. 51, 11 p., 147–157.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
CLL-IPI applied in Binet A CLL: a nationwide cohort study
Rotbain, E. C., da Cunha-Bang, C., Brieghel, C. & Niemann, Carsten, 2022, In: Blood advances. 6, 21, p. 5698-5701 4 p.Research output: Contribution to journal › Letter › Research › peer-review
ID: 185059285
Most downloads
-
184
downloads
Cocreated Smartphone App to Improve the Quality of Life of Adolescents and Young Adults with Cancer (Kræftværket): Protocol for a Quantitative and Qualitative Evaluation
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
152
downloads
Using Cocreation in the Process of Designing a Smartphone App for Adolescents and Young Adults With Cancer: Prototype Development Study
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
129
downloads
Machine learning can identify newly diagnosed patients with CLL at high risk of infection
Research output: Contribution to journal › Journal article › Research › peer-review
Published